Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2000
04/13/2000CA2345642A1 Methods for the treatment of non-thyroid disorders
04/13/2000CA2345580A1 Photosensitizers for photodynamic applications
04/13/2000CA2345577A1 2,3-disubstituted pyridine derivatives, process for the preparation thereof, drug compositions containing the same and intermediates for the preparation
04/13/2000CA2345213A1 Agent that retards transformation of hormone-dependent cancer to non-hormone-dependent cancer
04/13/2000CA2345212A1 Zinc finger-reactive antimicrobial compounds
04/13/2000CA2345209A1 Antisense modulation of integrin .alpha.4 expression
04/13/2000CA2345137A1 Mglur5 antagonists for the treatment of pain and anxiety
04/13/2000CA2345133A1 Naphthalenecarboxamides as tachykinin receptor antagonists
04/13/2000CA2344995A1 Cancer associated antigens and uses therefor
04/13/2000CA2344973A1 Oxidoreductase molecules
04/13/2000CA2344807A1 Naphthalenecarboxamides as tachykinin receptor antagonists
04/13/2000CA2344616A1 Antisense oligonucleotide modulation of tumor necrosis factor-.alpha. (tnf-.alpha.) expression
04/13/2000CA2344266A1 Cadherin-like asymmetry protein-1, and methods for its use
04/13/2000CA2341374A1 Quinoline and quinazoline derivatives and their use as inhibitors of cytokine mediated diseases
04/13/2000CA2341351A1 Alpha-2/delta gene
04/13/2000CA2341346A1 Non-peptide gnrh agents, methods and intermediates for their preparation
04/13/2000CA2318047A1 Tape material for transcutaneous absorption
04/13/2000CA2285818A1 Composition to enhance skin permeation of topical skin agents
04/13/2000CA2285812A1 Retinol stabilized cleansing compositions
04/12/2000EP0992510A1 N6 heterocyclic substituted adenosine derivatives
04/12/2000EP0992509A2 Novel macrolide derivatives
04/12/2000EP0992503A1 Process for producing isooxazolidinedione compound
04/12/2000EP0992502A1 2-(3-Phenyl-2-propenyl)-1,2,3,4-tetrahydro-isochinolin derivatives, process for their preparation and their use as fungicides
04/12/2000EP0992501A2 Pyridonecarboxylic acid derivatives as antibacterial agents
04/12/2000EP0992496A1 Annulated 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as CETP inhibitors
04/12/2000EP0992495A1 Process for obtaining quinapryl hydrochloride and solvates useful for isolating and purifying quinapryl hydrochloride
04/12/2000EP0992493A1 Substituted benzoylpiperidine derivatives and their use as Neurokinin antagonists
04/12/2000EP0992492A1 Small molecule inhibitors of rotamase enzyme activity
04/12/2000EP0992242A1 Vitamin d-containing preventives and/or remedies for conjunctival/corneal xerosis
04/12/2000EP0992241A1 Medicinal compositions against helicobacter pylori
04/12/2000EP0992240A1 Therapeutic agent for erection failure
04/12/2000EP0992239A1 Neuropeptide y receptor antagonist
04/12/2000EP0992238A1 Use of triclosan for preventing and treating mucosal and dermal conditions
04/12/2000EP0991773A1 CARBOHYDRATE COMPLEX EXTRACTED FROM $i(MYCOBACTERIUM TUBERCULOSIS) AND PROCESS FOR THE PREPARATION THEREOF
04/12/2000EP0991755A1 Oligonucleotide mediated specific cytokine induction and in vivo protection from infection
04/12/2000EP0991753A1 Protease inhibitors
04/12/2000EP0991741A1 WAX ESTERS ENRICHED IN $g(v)-3 UNSATURATED FATTY ACIDS, THEIR PREPARATION AND THEIR USE
04/12/2000EP0991691A1 Polymer comprising unsaturated ester units and pharmaceutical and cosmetic compositions thereof
04/12/2000EP0991670A1 Method for fixing or separating ions, in particular of lead, using per(3,6-anhydro) cyclodextrin derivatives
04/12/2000EP0991659A1 Peptides and compounds that bind to the il-5 receptor
04/12/2000EP0991654A1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same
04/12/2000EP0991653A1 Novel compounds
04/12/2000EP0991652A1 Tricyclic pyrazolo-pyridazinone analogues as gaba-a receptor ligands
04/12/2000EP0991650A1 Novel n-benzenesulphonyl-l-proline compounds, preparation method and use in therapy
04/12/2000EP0991649A1 Angiogenesis inhibiting thiadiazolyl pyridazine derivatives
04/12/2000EP0991648A1 4-haloalkyl-3- heterocyclylpyridines and 4-haloalkyl -5-heterocyclylpyridines, method for the production thereof, agents containing the same and their use as pesticides
04/12/2000EP0991647A1 Eprosartan monohydrate
04/12/2000EP0991646A1 An itraconazole exhibiting an improved solubility, a method of preparing the same and a pharmaceutical composition for oral administration comprising the same
04/12/2000EP0991645A1 Bis-indole derivatives having antimetastatic activity, a process for their preparation and pharmaceutical compositions containing them
04/12/2000EP0991644A1 Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors
04/12/2000EP0991643A1 Novel aminooxyamide tricyclic inhibitors of farnesylprotein transferase
04/12/2000EP0991642A1 2-aminoalkylaminoquinolines as dopamine d4 ligands
04/12/2000EP0991641A1 Omeprazole sodium salt
04/12/2000EP0991639A1 4- (1h-imidazol-4-yl)piperidin-1-yl]anilide derivatives, their preparation and application in therapy
04/12/2000EP0991638A1 NOVEL GUANIDINE MIMICS AS FACTOR Xa INHIBITORS
04/12/2000EP0991637A1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives as farnesyl protein transferase inhibitors
04/12/2000EP0991636A1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
04/12/2000EP0991632A1 New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives
04/12/2000EP0991630A1 Crystalline roxifiban
04/12/2000EP0991628A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56?lck TYROSINE KINASES
04/12/2000EP0991627A1 Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same
04/12/2000EP0991626A2 Pyrimidin-2,4,6-trion derivatives, method for producing the same and medicinal products containing these compounds
04/12/2000EP0991625A2 Inhibitors of factor xa with a neutral p1 specificity group
04/12/2000EP0991624A1 Phenylalkyl derivatives with thrombin-inhibiting effect
04/12/2000EP0991623A2 Quinoline-indole antimicrobial agents, uses and compositions related thereto
04/12/2000EP0991622A1 Substituted 3-(benzylamino)piperidine derivatives and their use as therapeutic agents
04/12/2000EP0991620A1 Pyrrolidine carboxylic acid derivatives as endothelin antagonists
04/12/2000EP0991619A1 INHIBITORS OF $g(a) 4?$g(b) 1?MEDIATED CELL ADHESION
04/12/2000EP0991618A1 Selective thyroid hormone analogs
04/12/2000EP0991616A1 METHOD FOR PRODUCING MEDICAMENTS CONTAINING HMG-CoA-REDUCTASE INHIBITORS
04/12/2000EP0991614A1 Synthesis of dihydrohonokiol compositions
04/12/2000EP0991426A1 Improved method for transferring nucleic acid into the striped muscle and combination therefor
04/12/2000EP0991424A1 Pharmaceutical compositions comprising an aldose reductase inhibitor and an ace inhibitor
04/12/2000EP0991417A1 Complex formation between dsdna and oligomer of heterocycles
04/12/2000EP0991415A1 Orally administrable solid ribavirin dosage forms and process for making them
04/12/2000EP0991414A1 Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists
04/12/2000EP0991413A1 Composition comprising a hydrolysed collagen protein and glucosamine for the treatment of arthroses
04/12/2000EP0991411A1 Treatment for pulmonary fibrosis
04/12/2000EP0991410A1 Gastrokinetic bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivates
04/12/2000EP0991409A1 Controlled release pharmaceutical compositions containing tiagabine
04/12/2000EP0991408A1 Novel process for manufacturing paroxetine solid dispersions
04/12/2000EP0991407A2 Stabilization of acid sensitive benzimidazols with amino/cyclodextrin combinations
04/12/2000EP0991406A1 Il-8 receptor antagonists
04/12/2000EP0991405A1 Clear, injectable formulation of an anesthetic compound
04/12/2000EP0991402A1 Poly(vinyl alcohol) cryogel
04/12/2000EP0862440A4 Therapeutic use of hemoglobin in promoting wound healing
04/12/2000EP0810829B1 Amino acid compositions and use thereof in clinical nutrition
04/12/2000EP0804414A4 Complementary dna and toxins
04/12/2000EP0799026B1 Hemolysis prevention by surfactants
04/12/2000EP0794951B1 Processes and intermediates for preparing cis (+) 3-[4,6-dihydroxychroman-3-ylmethyl]-4-methoxyaniline
04/12/2000EP0759917B1 Novel selective inhibitors of viral or bacterial neuraminidases
04/12/2000EP0707566B1 Novel structural analogues of vitamin d
04/12/2000EP0623623B1 2-aminoethanesulfonic acid/zinc complex
04/12/2000EP0621270B1 Piperazine derivatives as collagenase inhibitors
04/12/2000CN1250484A Diagnosis and treatment of glaucoma
04/12/2000CN1250448A Improved method for producing thiazolidinediones, and new thiazolidinediones
04/12/2000CN1250445A Sulfamide-metalloprotease inhibitors
04/12/2000CN1250444A 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (D4)
04/12/2000CN1250376A Treatment of infarcts through inhibition of NF-KAPPAB
04/12/2000CN1250374A Therapeutic combination of mineral and vitamin in units of liquid preparation for oral administration
1 ... 6335 6336 6337 6338 6339 6340 6341 6342 6343 6344 6345 6346 6347 6348 6349 6350 6351 6352 6353 6354 6355 ... 7860